LWBK1006-Index LWW-Govindan-Review December 19, 2011 19:14
598 IndexAll-trans retinoic acid (ATRA),
139, 440, 446
side effect of, 446
Aloe vera, 596
Alpha1-antitrypsin deficiency and
HCC, 253, 257
-tocopherol, 198, 202
-tubulin, 22, 31
Alpha-fetoprotein (AFP), 225, 252,
299, 302, 411–412
Alpha-Tocopherol, Beta-Carotene
Trial (ATBC), 139
Altered fractionation, 87, 92
Alveolar rhabdomyosarcoma, 370,
478
cytogenetic abnormality in, 481
Amegakaryocytic
thrombocytopenia, 224
American Association for the Study
of Liver Diseases, 257
American Cancer Society Cohort
Study, 61
American College of Cardiology, 81
American College of Obstetricians
and Gynecologists, 143, 146
American College of Physicians,
143, 146
American College of Radiology,
179
American Joint Committee on
Cancer staging system, 248
American Society of
Anesthesiologists Class, 78,
81
American Society of Clinical
Oncology (ASCO), 34, 45,
342
for cancer susceptibility
syndromes, 34, 45
Americans with Disabilities Act of
1990, 574, 578
Amides, usage of, 77, 81
Amifostine, in xerostomia, 558
Aminoglutethimide, 522
AML.SeeAcute myeloid leukemias
(AML)
AML1-ETO, 437, 443
AML/RUNX1, 460, 461
Anal cancer
in HIV patients, 500
treatment, chemoradiation with
5FU and mitomycin in, 272,
276
Anaphase, 17, 25
Anaphase promoting complex/
cyclosome (APC/C), 17, 25
in mitosis, 19, 28
Anaplastic large cell lymphoma
(ALCL), 414, 428Anaplastic thyroid carcinoma, 352,
359–360
concurrent chemoradiation and,
352, 360
Anastrozole, 128
in breast cancer, 338, 346
Androgen receptor, 287, 294–295
Anemia, in cancer patients, 518,
523
Angiogenesis, 2, 8
Angiopoietins, 21
Ankrin, 22, 31
Ankylosing spondylitis treatment,
radiation in, 58, 64
Anogenital cancers, 499, 501
Anorectal infections, 547–548
Antiangiogenic treatment
resistance, 22, 30
Antiapoptotic proteins, inhibition
of, 19
Antibiotic therapy, in neutropenic
fever, 540, 546
Antibody-based therapies,
limitations of, 108, 112
Anticholinergic drugs,
hyposalivation and, 577
Antiemetic therapy, with high
emetic risk chemotherapy,
552, 557
Antisense inhibition, 126
Anti-Yo antibody CNS
paraneoplastic disorder, 520,
524
AP-1.SeeActivator protein (AP-1)
APC/C.SeeAnaphase promoting
complex/cyclosome (APC/C)
APCgene, germ line mutations in,
46
APEX1 endonuclease, 12
APL.SeeAcute promyelocytic
leukemia (APL)
Aplastic anemia, 22, 30
Apoptosis, 19, 27
inhibition of, 96, 101
p53 in, 102
taxanes induce, 27
Appendiceal cancer and peritoneal
carcinomatosis, 487
Appendix, mucinous
adenocarcinoma of, 488, 493
APR.SeeAbdominoperineal
resection (APR)
Aromatase inhibitor (AI), 334
therapy
for breast cancer, 133
for postmenopausal breast
cancer patients, 133
usage of, 336, 344
Aromatic amines, 33, 43Arsenic trioxide, 446
for APL therapy, 439, 445
Arteriothrombotic events ,and
anti-VEGF therapy, 22, 30
Asbestos
lung cancer and, 60, 66
malignant peritoneal
mesothelioma and, 489, 494
pleural mesothelioma and, 57, 63
Ascites, 164, 174
ASCO.SeeAmerican Society of
Clinical Oncology (ASCO)
Ashkenazi descent
BRCA1 and, 312
BRCA2 and, 312
Ashkenazi Jews, 151, 157
BRCA mutation and, 137, 139
Askin’s tumor, 395, 405
Asparaginase, in acute
lymphoblastic leukemia
treatment, 127, 132
Aspergillus species, and halo sign,
541, 547
Aspirin, 139
Ataxia telangiectasia, 332, 341,
414
breast cancer and, 60, 65
Ataxic breathing, 507
ATBC.SeeAlpha-Tocopherol,
Beta-Carotene Trial (ATBC)
Atelomeric chromosomes, 14
ATL.SeeAdult T-cell leukemia
(ATL)
ATP.SeeAdenosine triphosphate
(ATP)
ATRA.SeeAll-trans retinoic acid
(ATRA)
ATR/CHK1 signaling, 4, 12
Atypical ductal hyperplasia (ADH),
143, 147
breast cancer risk and, 143, 147
Aurora B kinase, overexpression of,
5, 12
Autologous breast reconstruction,
335, 344
Autologous HCT, limitations of,
529, 535
Autologous stem cell
transplantation (ASCT), 450,
453–454, 473, 530, 536
complication associated with,
530, 537
in DLBCL, 417, 431
indications for, 530, 536
myelodysplastic syndrome in, 537
purging tumor cells from, 530,
536
andVaricella zosteroutbreaks,
537